MedTrace Logo

Comparison of Two Different Antiplatelet Preparations for an Unruptured Intracranial Aneurysm

NCT03581409 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 198

Last updated 2022-04-27

No results posted yet for this study

Summary

Perform a randomized comparison study of dual-antiplatelet (aspirin, prasugrel) and triple-antiplatelet (aspirin, clopidogrel, and cilostazol) preparation using P2Y12 assay in patients with high on-treatment platelet reactivity undergoing stent-assisted coil embolization for an unruptured intracranial aneurysm

Conditions

  • Aneurysm, Cerebral
  • Endovascular Procedures

Interventions

DRUG

Aspirin

Aspirin protect tablet

DRUG

Prasugrel

Prasugrel tablet

DRUG

Clopidogrel

Clopidogrel 75mg tablet

DRUG

Cilostazol

Cilostazol tablet

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    collaborator OTHER

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Seung Pil Ban, M.D. · Seoul National Bundang Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-24
Primary Completion
2021-01-22
Completion
2021-01-22

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03581409 on ClinicalTrials.gov